Medical treatment of active Crohn's disease
Open Access
- 31 May 2002
- journal article
- review article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 16, 35-39
- https://doi.org/10.1046/j.1365-2036.16.s4.16.x
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Mesalamine in the treatment of mild to moderate active Crohn's ileitis: Results of a randomized, multicenter trialGastroenterology, 1999
- A Randomized, Double-Blind, Placebo-Controlled Trial of the Oral Mesalamine (5-ASA) Preparation, Asacol, in the Treatment of Symptomatic Crohn??s Colitis and IleocolitisJournal of Clinical Gastroenterology, 1994
- Mesalamine capsules for the treatment of active Crohn's disease: Results of a 16-week trialGastroenterology, 1993
- Oral 5-Aminosalicyclic Acid Versus 6-Methylprednisolone in Active Crohn's DiseaseCanadian Journal of Gastroenterology and Hepatology, 1990
- Oral 5-ASA Versus Prednisone in Short Term Treatment of Crohn's Disease: A Multicentre Controlled TrialCanadian Journal of Gastroenterology and Hepatology, 1990
- Clinical Efficacy of Oral Mesalazine in Crohn’s DiseaseCanadian Journal of Gastroenterology and Hepatology, 1990
- Slow-Release 5-Amino-Salicylic Acid (Pentasa®) for the Treatment of Active Crohn’s DiseaseDigestion, 1990
- 5-Aminosalicylic Acid in the Treatment of Crohn's Disease: A 16-Week Double-Blind, Placebo-Controlled, Multicentre Study with Pentasa®Scandinavian Journal of Gastroenterology, 1986
- Effect of a Slow-Release 5´-Aminosalicylic Acid Preparation on Disease Activity in Crohn’s DiseaseDigestion, 1986
- Erfolgreiche Akutbehandlung chronisch-entzündlicher Darmerkrankungen mit oraler 5-AminosalicylsäureDeutsche Medizinische Wochenschrift (1946), 1985